Detalles de la búsqueda
1.
A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors.
Invest New Drugs
; 41(3): 493-502, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37171722
2.
An ErbB2 splice variant lacking exon 16 drives lung carcinoma.
Proc Natl Acad Sci U S A
; 117(33): 20139-20148, 2020 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32727899
3.
A FISH assay efficiently screens for BRAF gene rearrangements in pancreatic acinar-type neoplasms.
Mod Pathol
; 31(1): 132-140, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28884748
4.
A Novel PRKAR1B-BRAF Fusion in Gastrointestinal Stromal Tumor Guides Adjuvant Treatment Decision-Making During Pregnancy.
J Natl Compr Canc Netw
; 16(3): 238-242, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29523662
5.
The distribution of BRAF gene fusions in solid tumors and response to targeted therapy.
Int J Cancer
; 138(4): 881-90, 2016 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26314551
6.
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Cancer
; 122(17): 2654-62, 2016 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27284958
7.
DNA sequencing of cancer: what have we learned?
Annu Rev Med
; 65: 63-79, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24274178
8.
Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials.
Oncologist
; 21(6): 684-91, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27151654
9.
Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
Oncologist
; 21(1): 33-9, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26670666
10.
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
Oncologist
; 21(6): 762-70, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27245569
11.
FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.
J Transl Med
; 14(1): 339, 2016 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-27974047
12.
Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma.
Oncology
; 90(6): 339-46, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27207748
13.
Personalized Treatment for a Patient With a BRAF V600E Mutation Using Dabrafenib and a Tumor Treatment Fields Device in a High-Grade Glioma Arising From Ganglioglioma.
J Natl Compr Canc Netw
; 14(11): 1345-1350, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27799506
14.
Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.
Genes Chromosomes Cancer
; 54(10): 606-15, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26171757
15.
Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
Oncologist
; 20(10): 1132-9, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26336083
16.
Oncogenic alterations in ERBB2/HER2 represent potential therapeutic targets across tumors from diverse anatomic sites of origin.
Oncologist
; 20(1): 7-12, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25480824
17.
Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.
Oncologist
; 20(5): 499-507, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25882375
18.
Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations.
Breast Cancer Res Treat
; 154(1): 155-62, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26458824
19.
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1.
Proc Natl Acad Sci U S A
; 109(31): E2127-33, 2012 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-22773810
20.
Longitudinal Circulating Tumor DNA Modeling to Predict Disease Progression in First-Line Mutant Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer.
Clin Pharmacol Ther
; 115(2): 349-360, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38010260